A method for assessing the clinical efficacy of platelet-rich plasma

摘要

The present application provides a method for evaluating the clinical efficacy of platelet-rich plasma, including measuring the concentration of growth factors, cytokines and cells contained in platelet rich plasma (PRP), clinical efficacy evaluation of platelet-rich plasma It relates to a composition for use, a method for producing platelet-rich plasma, and a pharmaceutical composition for treating or preventing tendinopathy comprising platelet-rich plasma. According to the clinical efficacy evaluation method of platelet-rich plasma of the present application, by measuring the concentrations of cells, growth factors, and cytokines such as leukocytes, VEGF, and IL-8 contained in platelet-rich plasma, platelets with actual clinically therapeutic effect Since rich plasma can be selected, platelet-rich plasma can be efficiently used for disease treatment.